Announced
Completed
NXTHERA INC / BOSTON SCIENTIFIC CORPORATION / Acquisition / Private
Synopsis
Acquisition by Boston Scientific of NxThera, a developer of the Rezum® system, a minimally invasive treatment options for men with symptoms arising from of benign prostatic hyperplasia (BPH).
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.